Figure 4. System for antimicrobial resistance monitoring in diseased dogs and cats (from FY2017)

Figure 5. System for antimicrobial resistance monitoring in healthy dogs and cats (from FY2018)
Food Safety and Consumer Affairs Bureau, MAFF
Request for
cooperation

Public results
Contract the
project

Japan Veterinary
Medical Association
Request for
cooperation

Veterinary hospital

Report

National Veterinary Assay
Laboratory
Bacterial strains
and data

- Stoch bacterial strains
- Conduct molecular
epdemiological surveys, etc.

Contract laboratories

- Isolate and identify bacteria
(E. coli, Enterococcus spp.)
- Antimicrobial susceptibility
tests

Rectal swab

*In principle, 1 sample per
animal species per hospital

Veterinary hospital

Veterinary hospital

Quality control

Veterinary hospital

Veterinary hospital

3) Monitoring on the sales volumes of antimicrobials
An annual monitoring is conducted on the volumes of sales of veterinary antimicrobials, based on the reported quantities
of veterinary drugs handled by marketing authorization holders, pursuant to Article 71-2 of the Veterinary Drug Control
Regulations (MAFF Ordinance No. 107 of 2004) (Figure 6). Starting 2001, the monitoring has included the volume of
sales by active pharmaceutical ingredient, and the estimated percentage of sales by animal species, in addition to the
volumes of sales by antimicrobial class and route of administration. The data are aggregated and published on the website
of the National Veterinary Assay Laboratory as “Annual Report of Sales Amount and Sales Volume of Veterinary drugs,
Quasi-drugs and Medical Devices.” Under the OIE Terrestrial Animal Health Code’s section on antimicrobial usage
(Chapter 6.8), [4] these data are submitted to the OIE for the activity to understand and compare usage in each country of
the world.

94